Detalhe da pesquisa
1.
A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer.
Cell
; 177(5): 1330-1345.e18, 2019 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30982598
2.
PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer.
J Clin Oncol
; 32(29): 3212-20, 2014 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25199759
3.
Comparison of MammaPrint and TargetPrint results with clinical parameters in German patients with early stage breast cancer.
Int J Mol Med
; 26(6): 837-43, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21042777